Article

A novel multi-omics-based identification of symptoms, comorbid conditions, and possible long-term complications in COVID-19

2020-12-09

Abstract excerpt

<h4>ABSTRACT</h4> Till date the comprehensive clinical pictures, comorbid conditions, and long-term complications of COVID-19 are not known. Recently using a multi-omics-based strategy, we have predicted the drugs for COVID-19 management with ∼70% accuracy. Here, using a similar multi-omics-based bioinformatics approach and three-ways of analysis, we identified the symptoms, comorbid conditions, and short, mid and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 843c50b0-b006-58a4-af3e-dcac971dd56c
DOI: 10.1101/2020.12.08.20245753

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A novel multi-omics-based identification of symptoms, comorbid conditions, and possible long-term complications in COVID-19DOI 10.1101/2020.12.08.20245753Read

Complex patterns of multimorbidity associated with severe COVID-19 and Long COVIDSemantic proximity Read

Prediction of severe adverse events, modes of action and drug treatments for COVID-19's complications.Semantic proximity Read

COVID-19 Mortality is Associated with Impaired Innate Immunity in Pre-existing Health ConditionsSemantic proximity Read

An In-Depth Insight into Clinical, Cellular and Molecular Factors in COVID-19-Associated Cardiovascular Ailments for Identifying Novel Disease Biomarkers, Drug Targets and Clinical Management StrategiesSemantic proximity Read

MOATAI-VIR - an AI algorithm that predicts severe adverse events and molecular features for COVID-19’s complicationsSemantic proximity Read

Large-Scale Multi-omic Analysis of COVID-19 SeveritySemantic proximity Read

Omics-Based Computational Approaches for Biomarker Identification, Prediction, and Treatment of Long COVIDSemantic proximity Read

<strong></strong>An In-Depth Insight into Clinical, Cellular and Molecular Factors in COVID19-Associated Cardiovascular Ailments for Identifying Novel Disease Biomarkers, Drug Targets and Clinical Management StrategiesSemantic proximity Read

Severe acute infection and chronic pulmonary disease are risk factors for developing post-COVID-19 conditionsSemantic proximity Read

Severe Acute Infection and Chronic Pulmonary Disease are Risk Factors for Developing Post-COVID-19 ConditionsSemantic proximity Read

Clinical phenotypes and features of the post-COVID syndrome courseSemantic proximity Read

Integrative clinical, genomics and metabolomics data analysis for mainstream precision medicine to investigate COVID-19Semantic proximity Read